Assistant Professor, Medicine, UCSF School of Medicine

Internal Medicine

Robin Kelley practices Internal Medicine. She attended David Geffen School of Medicine at UCLA. David Geffen School of Medicine at UCLA is a top medical university. David Geffen School of Medicine at UCLA is ranked 13 in research and 7 in primary care medicine She received 1 awards: "CMS Meaningful Use Stage 1 Certification". Dr. Robin K. Kelley is a published doctor. She has 25 papers published. The most current publication "A phase I first-in-human study of Nesvacumab (REGN910), a fully-human anti-Angiopoietin-2 (Ang2) monoclonal antibody, in patients with advanced solid tumors."

Publications

---

• A phase I first-in-human study of Nesvacumab (REGN910), a fully-human anti-Angiopoietin-2 (Ang2) monoclonal antibody, in patients with advanced solid Tumors.
• Challenges of coverage policy development for next-generation tumor sequencing panels: experts and payers weigh in.
• Cases of Spontaneous Tumor Regression in Hepatobiliary Cancers: Implications for Immunotherapy?
• A Case Series of Patients with HER2-Overexpressed Primary Metastatic Gastroesophageal AdenoCarcinoma.
• Potent antitumor activity of Cabozantinib, a c-MET and VEGFR2 Inhibitor, in a Colorectal Cancer Patient-derived Tumor Explant Model.
• Genomic sequencing: assessing the health care system, policy, and big-data implications.
• (90)Y Glass Microspheres for the Treatment of Unresectable Metastatic Liver Disease from Chemotherapy-Refractory Gastrointestinal Cancers: A Pilot Study.
• Brivanib and FOLFOX in HepatoCellular Carcinoma: Finding the Common Themes Among Negative Trials.
• A phase 1 trial of imatinib, bevacizumab, and metronomic cyclophosphamide in advanced colorectal Cancer.
• Temsirolimus combined with sorafenib in hepatoCellular carcinoma: a phase I dose-finding trial with pharmacokinetic and biomarker correlates.
• Can we cure cholangioCarcinoma with neoadjuvant chemoradiation and liver transplantation? Time for a multicenter trial.
• Biomarker use in colorectal Cancer therapy.
• Salvage liver transplantation for recurrent hepatoCellular carcinoma after radiofrequency ablation: A new strategy?
• Prognostic and Predictive Markers in Stage II Colon Cancer: Is There a Role for Gene Expression Profiling?
• Optimizing the Administration of Fixed-Dose Rate Gemcitabine Plus Capecitabine Using an Alternating-week Schedule: A Dose Finding and Early Efficacy Study in Advanced ...
• Personalized medicine and oncology practice guidelines: a case study of contemporary biomarkers in colorectal Cancer.
• Nonadherence to imatinib during an economic downturn.
• Sorafenib in hepatoCellular carcinoma: separating the hype from the hope.
• Novel Therapeutics in HepatoCellular Carcinoma.
• NCCN Task Force report: Evaluating the clinical utility of tumor markers in oncology.
• A phase II study of bevacizumab plus erlotinib for gemcitabine-refractory metastatic pancreatic Cancer.
• "And what other medications are you taking?".
• Erlotinib in the treatment of advanced pancreatic Cancer.
• KRAS mutational analysis for colorectal Cancer. Application: pharmacogenomic.

Schools

---

• David Geffen School Of Medicine At UCLA University Of California Los Angeles

Conditions Treated

---

• Adrenal Gland Cancer
• Anal and Rectal Cancer
• Anemia
• Basal Cell Carcinoma
• View All

Doctors Specialties

---

• Hematology
• Medical Oncology
• Oncology
• Internal Medicine

Accepted Insurances

---

Awards

---

• CMS Meaningful Use Stage 1 Certification

Education

---

• UCSF
• UCLA Medical Center
• David Geffen School of Medicine at UCLA

Hospital

---

• San Francisco VA Medical Center
• UCSF Medical Center

Drug Facts

---

NPI NUMBER		1700805223
NPPES Provider LastName		KELLEY
NPPES Provider FirstName		ROBIN
NPPES Provider ZIPCode		90095
NPPES Provider State		CA
Specialty Description		Medical Oncology
Total Claim Count		243.0
Distinct Opioid Count		1.0
Opioid Claim Count		21.0
Percent Opioid Claims		8.64

Helpful Reviews

---

Give Anonymous Review

Medicare Facts

---

National Provider Identifier [NPI]	1700805223
Last Name Of The Provider	KELLEY
First Name Of The Provider	ROBIN
View All

Similar Doctors

---

	Dr. Daniel M. Wlodarczyk, MD This Doctor is OpenDoctor Recommended.
	Dr. Varun Saxena, MD This Doctor is OpenDoctor Recommended.
	Dr. Seth Blumberg, MD
	Dr. Kirsten N. Kangelaris, MD This Doctor is OpenDoctor Recommended.
	Dr. Kanako Y. McKee, MD This Doctor is OpenDoctor Recommended.
	Dr. Susan J. Kim, MD
	Dr. Lawrence W. White, MD This Doctor is OpenDoctor Recommended.
	Dr. Garrett A. Smith, MD This Doctor is OpenDoctor Recommended.
	Dr. May C. Chen, MD This Doctor is OpenDoctor Recommended.
	Dr. David H. Irwin, MD
	Dr. Alan B. Newman, MD
	Dr. Joan E. Etzell, MD This Doctor is OpenDoctor Recommended.
	Dr. Chuanyi M. Lu, MD This Doctor is OpenDoctor Recommended.
	Dr. Alan B. Glassberg, MD This Doctor is OpenDoctor Recommended.
	Dr. David Y. Lou, MD This Doctor is OpenDoctor Recommended.
	Dr. Franciscus M. Delen, MD This Doctor is OpenDoctor Recommended.
	Dr. Kim Huynh, MD

---

Doctor Directory | TOS | twitter | FB | Angel | blog